Merit Medical Systems Cash on Hand 2010-2023 | MMSI

Merit Medical Systems cash on hand from 2010 to 2023. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Merit Medical Systems Annual Cash on Hand
(Millions of US $)
2023 $587
2022 $58
2021 $68
2020 $57
2019 $44
2018 $67
2017 $32
2016 $19
2015 $4
2014 $7
2013 $7
2012 $10
2011 $10
2010 $4
2009 $6
Merit Medical Systems Quarterly Cash on Hand
(Millions of US $)
2023-12-31 $587
2023-09-30 $59
2023-06-30 $72
2023-03-31 $58
2022-12-31 $58
2022-09-30 $51
2022-06-30 $63
2022-03-31 $54
2021-12-31 $68
2021-09-30 $69
2021-06-30 $70
2021-03-31 $59
2020-12-31 $57
2020-09-30 $45
2020-06-30 $50
2020-03-31 $50
2019-12-31 $44
2019-09-30 $37
2019-06-30 $35
2019-03-31 $50
2018-12-31 $67
2018-09-30 $52
2018-06-30 $44
2018-03-31 $34
2017-12-31 $32
2017-09-30 $23
2017-06-30 $38
2017-03-31 $26
2016-12-31 $19
2016-09-30 $17
2016-06-30 $10
2016-03-31 $5
2015-12-31 $4
2015-09-30 $6
2015-06-30 $12
2015-03-31 $10
2014-12-31 $7
2014-09-30 $6
2014-06-30 $9
2014-03-31 $13
2013-12-31 $7
2013-09-30 $9
2013-06-30 $13
2013-03-31 $9
2012-12-31 $10
2012-09-30 $9
2012-06-30 $10
2012-03-31 $10
2011-12-31 $10
2011-09-30 $6
2011-06-30 $63
2011-03-31 $3
2010-12-31 $4
2010-09-30 $5
2010-06-30 $4
2010-03-31 $6
2009-12-31 $6
2009-09-30 $6
2009-06-30 $5
2009-03-31 $16
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $4.272B $1.257B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $69.513B 20.18
McKesson (MCK) United States $68.775B 18.41
West Pharmaceutical Services (WST) United States $28.373B 47.97
Cardinal Health (CAH) United States $25.885B 15.56
Align Technology (ALGN) United States $24.450B 49.30
Cooper (COO) United States $19.104B 28.91
Labcorp (LH) United States $17.372B 14.84
Henry Schein (HSIC) United States $9.226B 15.96
DENTSPLY SIRONA (XRAY) United States $6.640B 17.50
STAAR Surgical (STAA) United States $2.521B 79.39
CONMED (CNMD) United States $2.342B 22.05
Patterson (PDCO) United States $2.305B 11.04
Atrion (ATRI) United States $0.709B 36.55
Lifevantage (LFVN) United States $0.078B 12.67
Pro-Dex (PDEX) United States $0.065B 24.53
Biolase (BIOL) United States $0.005B 0.00